Gene · 80310
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence. | Clin Cancer Res | 2021 | 33028593 | PubTator, text mining | PubMed |
| Insights into glucocorticoid responses derived from omics studies. | Pharmacol Ther | 2021 | 32910934 | PubTator, text mining | PubMed |
| Microenvironmental modulation of the developing tumour: an immune-stromal dialogue. | Mol Oncol | 2021 | 32741067 | PubTator, text mining | PubMed |
| Stromal Platelet-Derived Growth Factor Receptor-β Signaling Promotes Breast Cancer Metastasis in the Brain. | Cancer Res | 2021 | 32327406 | PubTator, text mining | PubMed |
| The analysis of a ceRNA network and the correlation between lncRNA, miRNA, and mRNA in bladder cancer. | Transl Cancer Res | 2020 | 35117432 | PubTator, text mining | PubMed |
| Mechanistic models of signaling pathways deconvolute the glioblastoma single-cell functional landscape. | NAR Cancer | 2020 | 34316686 | PubTator, text mining | PubMed |
| Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis. | Front Mol Biosci | 2020 | 33681288 | PubTator, text mining | PubMed |
| Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases. | Front Immunol | 2020 | 33613514 | PubTator, text mining | PubMed |
| Periostin Contributes to Immunoglobulin a Nephropathy by Promoting the Proliferation of Mesangial Cells: A Weighted Gene Correlation Network Analysis. | Front Genet | 2020 | 33488671 | PubTator, text mining | PubMed |
| The Interactions of Nintedanib and Oral Anticoagulants-Molecular Mechanisms and Clinical Implications. | Int J Mol Sci | 2020 | 33396592 | PubTator, text mining | PubMed |
| Aberrantly Methylated-Differentially Expressed Genes Identify Novel Atherosclerosis Risk Subtypes. | Front Genet | 2020 | 33381146 | PubTator, text mining | PubMed |
| MiRNA-Mediated Subpathway Identification and Network Module Analysis to Reveal Prognostic Markers in Human Pancreatic Cancer. | Front Genet | 2020 | 33362865 | PubTator, text mining | PubMed |
| Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia. | Epigenomics | 2020 | 33350853 | PubTator, text mining | PubMed |
| CD8+ T Cell Co-Expressed Genes Correlate With Clinical Phenotype and Microenvironments of Urothelial Cancer. | Front Oncol | 2020 | 33330025 | PubTator, text mining | PubMed |
| Computational study on natural compounds inhibitor of c-Myc. | Medicine (Baltimore) | 2020 | 33327259 | PubTator, text mining | PubMed |
| Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway. | Front Vet Sci | 2020 | 33324695 | PubTator, text mining | PubMed |
| SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations. | iScience | 2020 | 33305187 | PubTator, text mining | PubMed |
| Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy. | Cells | 2020 | 33291749 | PubTator, text mining | PubMed |
| 'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension. | Genes (Basel) | 2020 | 33256119 | PubTator, text mining | PubMed |
| Microarray analysis identification of key pathways and interaction network of differential gene expressions during osteogenic differentiation. | Hum Genomics | 2020 | 33234152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/papers?page=31